Increased microRNA-93-5p inhibits osteogenic differentiation by targeting bone morphogenetic protein-2

Background and purpose Trauma-induced osteonecrosis of the femoral head (TIONFH) is a major complication of femoral neck fractures. Degeneration and necrosis of subchondral bone can cause collapse, which results in hip joint dysfunction in patients. The destruction of bone metabolism homeostasis is an important factor for osteonecrosis. MicroRNAs (miRNAs) have an important role in regulating osteogenic differentiation, but the mechanisms underlying abnormal bone metabolism of TIONFH are poorly understood. In this study, we screened specific miRNAs in TIONFH by microarray and further explored the mechanism of osteogenic differentiation. Design Blood samples from patients with TIONFH and patients without necrosis after trauma were compared by microarray, and bone collapse of necrotic bone tissue was evaluated by micro-CT and immunohistochemistry. To confirm the relationship between miRNA and osteogenic differentiation, we conducted cell culture experiments. We found that many miRNAs were significantly different, including miR-93-5p; the increase in this miRNA was verified by Q-PCR. Comparison of the tissue samples showed that miR-93-5p expression increased, and alkaline phosphatase (ALP) and osteopontin (OPN) levels decreased, suggesting miR-93-5p may be involved in osteogenic differentiation. Further bioinformatics analysis indicated that miR-93-5p can target bone morphogenetic protein 2 (BMP-2). A luciferase gene reporter assay was performed to confirm these findings. By simulating and/or inhibiting miR-93-5p expression in human bone marrow mesenchymal stem cells, we confirmed that osteogenic differentiation-related indictors, including BMP-2, Osterix, Runt-related transcription factor, ALP and OPN, were decreased by miR-93-5p. Conclusion Our study showed that increased miR-93-5p in TIONFH patients inhibited osteogenic differentiation, which may be associated with BMP-2 reduction. Therefore, miR-93-5p may be a potential target for prevention of TIONFH.

[1]  D. Fritz,et al.  A polymorphism in a conserved posttranscriptional regulatory motif alters bone morphogenetic protein 2 (BMP2) RNA:protein interactions. , 2006, Molecular endocrinology.

[2]  Kozo Nakamura,et al.  Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[3]  R. O’Keefe,et al.  BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development , 2011, Journal of Cell Science.

[4]  M F Roizen,et al.  A proposal to use confidence intervals for visual analog scale data for pain measurement to determine clinical significance. , 1993, Anesthesia and analgesia.

[5]  A. Brunet,et al.  The microRNA cluster miR-106b~25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation , 2011, Aging.

[6]  R. Schmelzeisen,et al.  Follow-Up of Implant Survival Comparing Ficoll and Bone Marrow Aspirate Concentrate Methods for Hard Tissue Regeneration with Mesenchymal Stem Cells in Humans , 2014, BioResearch open access.

[7]  W. Richter,et al.  Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: rescue by chondrogenic pre-induction. , 2013, Stem cell research.

[8]  Choung-Soo Kim,et al.  miR‐140‐5p suppresses BMP2‐mediated osteogenesis in undifferentiated human mesenchymal stem cells , 2014, FEBS letters.

[9]  Shiek S. S. J. Ahmed,et al.  Polycaprolactone scaffold engineered for sustained release of resveratrol: therapeutic enhancement in bone tissue engineering , 2013, International journal of nanomedicine.

[10]  Min Liu,et al.  MicroRNA‐7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells , 2013, FEBS letters.

[11]  Di Chen,et al.  MicroRNA‐204 Regulates Runx2 Protein Expression and Mesenchymal Progenitor Cell Differentiation , 2009, Stem cells.

[12]  M. Rogers,et al.  Turning Bone Morphogenetic Protein 2 (BMP2) on and off in Mesenchymal Cells , 2015, Journal of cellular biochemistry.

[13]  Yalin Li,et al.  Genistein Promotion of Osteogenic Differentiation through BMP2/SMAD5/RUNX2 Signaling , 2013, International journal of biological sciences.

[14]  Harshini Sarojini,et al.  Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1 , 2011, Mechanisms of Ageing and Development.

[15]  Q. Bi,et al.  Altered MicroRNA Expression Profile in Exosomes during Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells , 2014, PloS one.

[16]  O. Maes,et al.  Murine microRNAs implicated in liver functions and aging process , 2008, Mechanisms of Ageing and Development.

[17]  H. Ryoo,et al.  Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation* , 2006, Journal of Biological Chemistry.

[18]  Seongsoo Hwang,et al.  SMILE inhibits BMP-2-induced expression of osteocalcin by suppressing the activity of the RUNX2 transcription factor in MC3T3E1 cells. , 2014, Bone.

[19]  H. Schliephake,et al.  Regulation of Multilineage Gene Expression and Apoptosis during in vitro Expansion of Human Bone Marrow Stromal Cells with Different Cell Culture Media , 2010, Cells Tissues Organs.

[20]  R. John Lye,et al.  MicroRNA-93 Controls Perfusion Recovery After Hindlimb Ischemia by Modulating Expression of Multiple Genes in the Cell Cycle Pathway , 2013, Circulation.

[21]  M. Kassem,et al.  Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone‐forming capacity , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  J. S. Heo,et al.  Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue , 2015, International journal of molecular medicine.

[23]  Jie Yang,et al.  MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8 , 2011, Oncogene.

[24]  Amitabha Bandyopadhyay,et al.  Genetic Analysis of the Roles of BMP2, BMP4, and BMP7 in Limb Patterning and Skeletogenesis , 2006, PLoS genetics.

[25]  R. Tuan,et al.  Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrow , 2007, Stem cells.

[26]  C. Marsit,et al.  MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer , 2015, Molecular Cancer.

[27]  Qian Zhang,et al.  MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating , 2015, Tumor Biology.

[28]  Minoru Yoshida,et al.  Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation* , 2006, Journal of Biological Chemistry.

[29]  E. Rooij,et al.  Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension‐induced heart failure , 2013, European journal of heart failure.

[30]  Yang Zhang,et al.  Clinical significance of microRNA-93 downregulation in human colon cancer , 2013, European journal of gastroenterology & hepatology.

[31]  microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells , 2015, Journal of experimental & clinical cancer research : CR.

[32]  S. Kuroda,et al.  Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium—Safety and Efficacy of Clinical Use for Neurotransplantation , 2011, Translational Stroke Research.

[33]  C. Tabin,et al.  BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing , 2006, Nature Genetics.

[34]  W. Harris,et al.  The Harris hip score: comparison of patient self-report with surgeon assessment. , 2001, The Journal of arthroplasty.

[35]  Yi Yang,et al.  Repetitive magnetic stimulation promotes neural stem cells proliferation by upregulating MiR-106b in vitro , 2015, Journal of Huazhong University of Science and Technology [Medical Sciences].